CONTINUOUS GLUCOSE MONITORING: A CONSENSUS CONFERENCE OF THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY

被引:125
|
作者
Fonseca, Vivian A. [1 ,2 ]
Grunberger, George [3 ,4 ,5 ,6 ]
Anhalt, Henry [7 ]
Bailey, Timothy S. [8 ,9 ]
Blevins, Thomas [10 ]
Garg, Satish K. [11 ,12 ,13 ]
Handelsman, Yehuda [14 ,15 ]
Hirsch, Irl B. [16 ]
Orzeck, Eric A. [17 ]
Roberts, Victor Lawrence [18 ]
Tamborlane, William [19 ]
机构
[1] Tulane Univ, Hlth Sci Ctr, Med & Pharmacol, Tullis Tulane Alumni Chair Diabet, New Orleans, LA 70118 USA
[2] Tulane Univ, Hlth Sci Ctr, Endocrinol Sect, New Orleans, LA 70118 USA
[3] Wayne State Univ, Sch Med, Grunberger Diabet Inst, Bloomfield Hills, Detroit, MI USA
[4] Wayne State Univ, Sch Med, Internal Med & Mol Med & Genet, Detroit, MI USA
[5] Oakland Univ, William Beaumont Sch Med, Internal Med, Rochester, MI 48063 USA
[6] Charles Univ Prague, Internal Med, Fac Med 1, Prague, Czech Republic
[7] T1D Exchange, Boston, MA USA
[8] AMCR Inst, San Diego, CA USA
[9] UCSD Sch Med, San Diego, CA USA
[10] Texas Diabet & Endocrinol, Austin, TX USA
[11] Univ Colorado Denver, Barbara Davis Ctr Diabet, Med & Pediat, Aurora, CO USA
[12] Univ Colorado Denver, Barbara Davis Ctr Diabet, Adult Program, Aurora, CO USA
[13] Univ Colorado Denver, Barbara Davis Ctr Diabet, Diabet Technol & Therapeut, Aurora, CO USA
[14] Metab Inst Amer, Tarzana, CA USA
[15] Amer Coll Endocrinol, Tarzana, CA USA
[16] Univ Washington, Sch Med, Med, Seattle, WA USA
[17] Endocrinol Associates, Houston, TX USA
[18] Univ Cent Florida, Coll Med, Internal Med, Orlando, FL 32816 USA
[19] Yale Univ, Sch Med, Pediat Endocrinol, New Haven, CT USA
关键词
AUGMENTED PUMP THERAPY; CHILDREN AGED 4; COST-EFFECTIVENESS; HEMOGLOBIN A1C; FOLLOW-UP; TYPE-1; INSULIN; HYPOGLYCEMIA; REDUCTION; SAFETY;
D O I
10.4158/EP161392.CS
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective/Methods: Barriers to continuous glucose monitoring (CGM) use continue to hamper adoption of this valuable technology for the management of diabetes. The American Association of Clinical Endocrinologists and the American College of Endocrinology convened a public consensus conference February 20, 2016, to review available CGM data and propose strategies for expanding CGM access. Results: Conference participants agreed that evidence supports the benefits of CGM in type 1 diabetes and that these benefits are likely to apply whenever intensive insulin therapy is used, regardless of diabetes type. CGM is likely to reduce healthcare resource utilization for acute and chronic complications, although real-world analyses are needed to confirm potential cost savings and quality of life improvements. Ongoing technological advances have improved CGM accuracy and usability, but more innovations in human factors, data delivery, reporting, and interpretation are needed to foster expanded use. The development of a standardized data report using similar metrics across all devices would facilitate clinician and patient understanding and utilization of CGM. Expanded CGM coverage by government and private payers is an urgent need. Conclusion: CGM improves glycemic control, reduces hypoglycemia, and may reduce overall costs of diabetes management. Expanding CGM coverage and utilization is likely to improve the health outcomes of people with diabetes.
引用
收藏
页码:1008 / 1021
页数:14
相关论文
共 50 条
  • [31] CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE ALGORITHM-2020 EXECUTIVE SUMMARY
    Handelsman, Yehuda
    Jellinger, Paul S.
    Guerin, Chris K.
    Bloomgarden, Zachary T.
    Brinton, Eliot A.
    Budoff, Matthew J.
    Davidson, Michael H.
    Einhorn, Daniel
    Fazio, Sergio
    Fonseca, Vivian A.
    Garber, Alan J.
    Grunberger, George
    Krauss, Ronald M.
    Mechanick, Jeffrey, I
    Rosenblit, Paul D.
    Smith, Donald A.
    Wyne, Kathleen L.
    ENDOCRINE PRACTICE, 2020, 26 (10) : 1196 - 1224
  • [32] CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM-2015 EXECUTIVE SUMMARY
    Garber, Alan J.
    Abrahamson, Martin Julian
    Barzilay, Joshua I.
    Blonde, Lawrence
    Bloomgarden, Zachary T.
    Bush, Michael A.
    Dagogo-Jack, Samuel
    Davidson, Michael B.
    Einhorn, Daniel
    Garber, Jeffrey R.
    Garvey, W. Timothy
    Grunberger, George
    Handelsman, Yehuda
    Hirsch, Irl B.
    Jellinger, Paul S.
    McGill, Janet B.
    Mechanick, Jeffrey I.
    Rosenblit, Paul David
    Umpierrez, Guillermo E.
    ENDOCRINE PRACTICE, 2015, 21 (12) : 1403 - 1414
  • [33] AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY CLINICAL PRACTICE GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS-2016
    Camacho, Pauline M.
    Petak, Steven M.
    Binkley, Neil
    Clarke, Bart L.
    Harris, Steven T.
    Hurley, Daniel L.
    Kleerekoper, Michael
    Lewiecki, E. Michael
    Miller, Paul D.
    Narula, Harmeet S.
    Pessah-Pollack, Rachel
    Tangpricha, Vin
    Wimalawansa, Sunil J.
    Watts, Nelson B.
    ENDOCRINE PRACTICE, 2016, 22 : 1 - 42
  • [34] AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY DISEASE STATE CLINICAL REVIEW: POSTOPERATIVE MANAGEMENT FOLLOWING PITUITARY SURGERY
    Woodmansee, Whitney W.
    Carmichael, John
    Kelly, Daniel
    Katznelson, Laurence
    ENDOCRINE PRACTICE, 2015, 21 (07) : 832 - 838
  • [35] AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE - EXECUTIVE SUMMARY
    Jellinger, Paul S.
    Handelsman, Yehuda
    Rosenblit, Paul D.
    Bloomgarden, Zachary T.
    Fonseca, Vivian A.
    Garber, Alan J.
    Grunberger, George
    Guerin, Chris K.
    Bell, David S. H.
    Mechanick, Jeffrey I.
    Pessah-Pollack, Rachel
    Wyne, Kathleen
    Smith, Donald
    Brinton, Eliot A.
    Fazio, Sergio
    Davidson, Michael
    ENDOCRINE PRACTICE, 2017, 23 (04) : 479 - 497
  • [37] RE: CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM-2019 EXECUTIVE SUMMARY
    Garber, Alan J.
    ENDOCRINE PRACTICE, 2019, 25 (06) : 623 - 623
  • [38] American Association of Clinical Endocrinologists/American College of Endocrinology Clinical Practice Guidelines for the Diagnosis and Treatment of Postmenopausal Osteoporosis-2020 Update
    Watts, Nelson B.
    Camacho, Pauline M.
    Lewiecki, E. Michael
    Petak, Steven M.
    ENDOCRINE PRACTICE, 2021, 27 (04) : 379 - 380
  • [39] AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY DISEASE STATE CLINICAL REVIEW: A NEUROENDOCRINE APPROACH TO PATIENTS WITH TRAUMATIC BRAIN INJURY
    Tritos, Nicholas A.
    Yuen, Kevin C. J.
    Kelly, Daniel F.
    ENDOCRINE PRACTICE, 2015, 21 (07) : 823 - 831
  • [40] AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS/AMERICAN COLLEGE OF ENDOCRINOLOGY CLINICAL PRACTICE GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS-2020 UPDATE
    Camacho, Pauline M.
    Petak, Steven M.
    Binkley, Neil
    Diab, Dima L.
    Eldeiry, Leslie S.
    Farooki, Azeez
    Harris, Steven T.
    Hurley, Daniel L.
    Kelly, Jennifer
    Lewiecki, E. Michael
    Pessah-pollack, Rachel
    McClung, Michael R.
    Wimalawansa, Sunil J.
    Watts, Nelson B.
    ENDOCRINE PRACTICE, 2020, 26 : 1 - 46